Linde Lowers Guidance on Weak Growth, U.S. Price Cuts
December 01 2015 - 2:19AM
Dow Jones News
By Monica Houston-Waesch
FRANKFURT--Linde AG (LIN.XE) ratcheted down its mid-term goals
for 2017 late Monday, primarily due to significantly slower
industrial production growth and U.S. healthcare market price
reductions.
The industrial gases group also said its engineering division
will contribute less than planned to operating profit, since low
oil prices are making customers hesitant to invest.
Operating profit in 2017 is likely to be between 4.2 billion
($4.45 billion) and EUR4.5 billion, down from its former forecast
range of EUR4.5 billion to EUR4.7 billion.
Linde now expects return on capital employed to be between 9%
and 10% in 2017, below its previous forecast of 11% to 12%.
"The state-controlled price reductions in the U.S. healthcare
market in 2016 and 2017 are expected to be stronger than originally
assumed," when the previous forecasts were made in October 2014,
Linde said.
Linde's adjusted targets for 2017 are based on current exchange
rates, the company said.
-Write to Monica Houston-Waesch at nikki.houston@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
December 01, 2015 02:04 ET (07:04 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.